Sponsor pipeline

NanOlogy, LLC clinical trial pipeline

Get alerts when NanOlogy, LLC's trials change

1 active trials 0 recruiting 1 disease areas 1 changes in 30 days

Data updated daily from ClinicalTrials.gov, last refresh 2026-08-28

What changed in the last 30 days

2026-08-19
Primary endpoint(s) modified
NCT07767110 Targeted LSAM-Cisplatin Infusion in Gliomas, Evaluation of Response · Phase 1/2

New trial filings, last 30 days

First postedTrialPhaseStatus
2026-08-17 NCT07767110 Targeted LSAM-Cisplatin Infusion in Gliomas, Evaluation of Response Phase 1/2 Not Yet Recruiting

Active trials by phase

Phase 1/2
1

Active trials

NCT IDTitleConditionStatusUpdated
Phase 1/2
NCT07767110 Targeted LSAM-Cisplatin Infusion in Gliomas, Evaluation of Response Diffuse Midline Glioma (DMG) Not Yet Recruiting 2026-08-18

Disease areas by active trials

Glioma (1)

Get alerts when NanOlogy, LLC's trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free